摘要
目的 :评价抗凝药物治疗肺血栓栓塞症的临床应用情况。方法 :通过临床研究 ,结合近期国外相关文献进行分析、评价。结果和结论 :抗凝治疗能使非大面积急性肺血栓栓塞症 (PTE)患者改善症状 ,降低病死率 ,且医疗费用较低廉 ,其复发率也较低 ,故从 2 0世纪 6 0年代以来 ,已逐渐成为急性PTE的基本治疗方法。目前临床上应用的抗凝药物主要有普通肝素。
OBJECTIVE:To evaluate clinical usage of anticoagulant drugs in the treatment of pulmonary thromboembolism(PTE). METHODS: To combine clinical study with recent literatures at abroad for analysis and assessment.RESULTS & CONCLUSION: Anticoagulant treatment can improve the symptoms with non-extensive acute PTE and decrease the mortality. Its medical cost is low and the recurrence is also low. So since the sixties of the 20 th century, anticoagulant treatment has gradually become the basic treatment for acute PTE. Now the major anticoagulant drugs used in the clinic are heparin, dalteparin sodium and warfarin.
出处
《中国医院用药评价与分析》
2003年第2期71-74,共4页
Evaluation and Analysis of Drug-use in Hospitals of China
基金
国家"十五"攻关课题"肺栓塞规范性诊断和治疗研究"的资助
